Institute of Cardiovascular Sciences We are leaders in cardiovascular research, including atrial fibrillation and heart failure, thrombosis and haemostasis, and vascular biology.
News Study outlines mechanism behind rare blood clots linked to COVID-19 vaccine New research carried out in collaboration with the University of Birmingham has characterised a rare COVID-19 vaccine-induced syndrome which causes blood clots.
News New research award to investigate and treat thrombo-inflammation in diseases where red blood cell destruction occurs
News Clinical trial led by Bimingham Professor shows digoxin is effective for treatment of atrial fibrillation
Posted 15 June 2021 Professor's success story used to mark BHF's 60th birthday celebrations Professor Paulus Kirchhof's success story of the the EAST-AFNET 4 clinical trial has been featured in the BHF's 60th birthday celebrations.
Posted 06 May 2021 University of Birmingham joins drug discovery collaboration with Evotec and Bristol Myers Squibb The University of Birmingham is part of a new industry collaboration launched to accelerate drug discovery projects that will fast track research from lab to patient.
Posted 23 April 2021 Study outlines mechanism behind rare blood clots linked to COVID-19 vaccine New research carried out in collaboration with the University of Birmingham has characterised a rare COVID-19 vaccine-induced syndrome which causes blood clots.
Posted 21 April 2021 Birmingham Health Innovation Campus takes another step forward after planning permission granted Work is set to begin on the first phase of Birmingham Health Innovation Campus this Summer after planning permission was granted by Birmingham City Council.